Forgot Password

Sign In

Register

  • Company Information

  • Billing Address

  • Are you primarily interested in advertising *

  • Do you want to recieve the HealthTimes Newsletter?

  • Major funding boost for detecting diabetes in pregnancy in rural communities

    Author: Charlotte Mitchell

A ground-breaking project set up to protect the health of Aboriginal mothers and their families in rural communities by optimising the screening and management of hyperglycaemia in pregnancy has received a $3.2 million funding boost from the Medical Research Future Fund.

Professor Julia Marley, a Senior Principal Research Fellow from The University of Western Australia’s Medical School and the Rural Clinical School of WA, is chief investigator of the ORCHID Study - a collaboration between the Rural Clinical School of WA, Kimberley Aboriginal Medical Services and their member services, Diabetes WA and WA Country Health Services.

Subscribe for FREE to the HealthTimes magazine



In welcoming the funding, Professor Marley said diabetes disproportionately impacts the lives of Aboriginal people, with predisposition beginning in pregnancy.

“Hyperglycaemia or high blood glucose in pregnancy increases babies' risk of birth defects and being born premature and by caesarean, as well as being born larger or smaller than optimum, with low blood glucose levels, and difficulty breathing,” Professor Marley said in an official statement.

“Babies have increased risk for obesity and altered glucose metabolism in childhood and for future diabetes, and mothers have increased risk for future diabetes and cardiovascular disease – it is a significant and far-reaching health issue, particularly affecting remote and rural communities.”

FEATURED JOBS

Registered Nurse - Surgical
St Vincent's Private Hospital
Anaesthetics Specialist
Omega Medical Pty Ltd
Womens Imaging Sonographer
South Coast Radiology


Ms Erica Spry, Bardi Jawi traditional owner and co-chief investigator from the Kimberley Aboriginal Medical Services and the Rural Clinical School of WA, said the new funding would allow the project to implement, evaluate and refine the alternative screening that earlier phases of this study identified for detecting high blood glucose in pregnancy at regional, state and national levels.

“The ORCHID Study is to benefit all ethnicities, especially our Aboriginal women, it is important to acknowledge all the women across WA who have participated in the ORCHID Study, we thank you all,” Ms Spry said in a statement.

“With this grant, we will begin sharing  sugar management tools to help assist Aboriginal women with managing their high blood glucose levels in pregnancy and work on ways to support the family of the expecting mums. This funding will help us bring benefits back to our community members.

“As already proven effective, we’ll use three-way learning between Aboriginal community members, health providers and researchers to co-design and trial self-management strategies for high blood glucose in pregnancy.

“We want to help and assist empower Aboriginal women and their families to make positive lifestyle choices aimed at improving birth outcomes and health for subsequent pregnancies and prevent or delay progression to chronic disease.”

Comments

Thanks, you've subscribed!

Share this free subscription offer with your friends

Email to a Friend


  • Remaining Characters: 500

Charlotte Mitchell

Charlotte is a published journalist and editor, with 10 years of experience in developing high-quality content for national and international publications.

With an academic background in both science and communications, she specialises in medical and science writing. Charlotte is passionate about creating engaging, evidence-based content that equips the community with important information on issues around healthcare, medicine and research.

Over the years, she has partnered with organisations including the Medical Journal of Australia, Cancer Council NSW, Bupa, the Australasian Medical Publishing Company, Dementia Australia, MDA National, pharmaceutical companies, and state and federal government agencies, to produce high-impact news and clinical content  for different audiences.